Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
2023 · Cell Reports Medicine · 160 citations
https://doi.org/10.1016/j.xcrm.2022.100881
K
Ke Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
202
Papers
5.7K
Citations
45
h-index
110
i10-index
Ke Xu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Cancer Cells and Metastasis. The author has an h-index of 45, co-authored 172 publications.
ORCID: 0000-0002-3942-2767Papers by this author
worksBoosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor
2024 · Bioactive Materials · 123 citations
https://doi.org/10.1016/j.bioactmat.2024.02.016
miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2
2012 · Biochemical Journal · 93 citations
https://doi.org/10.1042/bj20120386
Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells
2018 · Journal of Pharmacological Sciences · 50 citations
https://doi.org/10.1016/j.jphs.2018.11.013
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
2018 · Journal of Hematology & Oncology · 48 citations
https://doi.org/10.1186/s13045-018-0659-4
Swimming Exercise Alleviates Endothelial Mitochondrial Fragmentation via Inhibiting Dynamin-Related Protein-1 to Improve Vascular Function in Hypertension
2022 · Hypertension · 41 citations
https://doi.org/10.1161/hypertensionaha.122.19126
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat